ChemoCentryx, Inc. (CCXI) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Speaker 1: Good afternoon and welcome to the Chemocentrics Speaker 1: 4th 0.25 and full year 2021 Speaker 1: financial results conference call. Speaker 1: At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. Speaker 1: As a reminder, this conference call will be recorded. Speaker 1: And I would now like to turn the call over to Bill Slattery, Jr., Vice President of Investor Relations and Corporate Communications at Chemocentrics. Speaker 1: Mr. Slattery, Speaker 1: please go ahead. Speaker 2: Thank you, operator. Speaker 2: Good afternoon and welcome to the Chemocentrics Speaker 2: 4th 0.25 and full year 2021 Speaker 2: financial results conference call. Speaker 2: For those of you I have not yet met, I recently joined Chemocentrics as head of investor relations and corporate communications. Speaker 2: My contact information can be found at the bottom of the press release we issued earlier this afternoon, Speaker 2: providing an overview of our financial results for the 0.25 and year ended December 31st, 2021. This Speaker 2: press release, along with a slide deck that you may find helpful while you listen to this call, are available on the Investor Relations section of our website at www.chemocentrics.com. Speaker 2: Joining us on the call today from Chemocentrics Speaker 2: are Dr. Thomas Schall, President, Chief Executive Officer, and Chairman of the Board, Speaker 2: Susan Kanaya, Executive Vice President, Chief Financial and Administrative Officer, Speaker 2: and Tash Abad, Speaker 2: Executive Vice President and Chief Operations Officer. Speaker 2: Tom and Susan will make introductory remarks before we open the call to your questions. Speaker 2: During today's call, we will be making certain forward-loo...